Latest Asx News

Matrix Composites & Engineering has clarified details of a conditional merger proposal with Advanced Innergy Solutions, highlighting a significant shift in shareholding and advising shareholders to await further updates.

Raptis Group Limited has had its trading suspension lifted following the announcement of a placement and a pro-rata non-renounceable entitlement offer, signaling a fresh chapter for the company on the ASX.

Raptis Group Limited has completed a $225,000 private placement and launched a fully underwritten $1.75 million entitlement offer, aiming to expand its property management portfolio with a possible Broadbeach acquisition.

ADX Energy has formalised licence amendments and identified four drill-ready shallow gas prospects in Upper Austria, targeting Q4 2025 for initial drilling. The company is advancing farm-in discussions to capitalise on a low-risk, pipeline-proximate gas opportunity in a sought-after European market.

IMEXHS Limited reported robust FY24 growth and launched its AI-enabled medical imaging platform Aquila+, setting the stage for expected profitability and accelerated revenue in 2025.

Adherium Limited has locked in $900,000 through convertible notes to fund the expansion of its Hailie® Smartinhaler® platform in the US, pending shareholder approval at the upcoming AGM.

HeraMED faces a setback as Broward Health discontinues its HeraCARE platform amid Medicaid funding cuts, prompting a strategic pivot with new leadership and partnerships to accelerate US growth.

Emu NL’s recent shareholder meeting saw all attempts to remove or elect new directors decisively rejected, reinforcing board stability as the company completes a planned capital raise.

UVRE Limited is set to acquire New Zealand gold explorer Otagold Limited, issuing 75 million shares as consideration and raising $4 million to fund exploration. The move significantly broadens UVRE’s exposure to high-potential gold projects in a tier 1 mining jurisdiction.

Uvre Limited is set to acquire New Zealand gold explorer Otagold, backed by a $4 million equity raise and the appointment of mining veterans Norman Seckold and Peter Nightingale to its board.

Lumos Diagnostics has secured Medicare reimbursement for its FebriDx test from a fifth contractor, covering more than 70% of US Medicare payments and advancing its commercial reach.

Anatara Lifesciences has expanded its intellectual property footprint with a 20-year patent granted in Hong Kong for its GaRP gastrointestinal health product, following similar approvals in Europe and Australia. This milestone strengthens its commercial position in the lucrative global market for digestive health solutions.